New: NCI-funded clinical trial search
Mednet Logo

Which patients would benefit most from teplizumab therapy to delay the onset of T1DM?

Herold et al., PMID 31180194
Community PollStarted

Would you consider using teplizumab for adults diagnosed with latent autoimmune diabetes in adults who are not on insulin but test positive for one antibody?

27 physicians have voted

Join Mednetto vote and see how they answered.

2 Answers
Mednet Member
Mednet MemberInvited Expert
Endocrinology · Brigham And Womens Hospital Endocrinology
Answered on

First, for full disclosure, I am an adult endocrinologist and I have not prescribed teplizumab so what I will say is what I have distilled from reading the literature and discussing this topic with colleagues.

Teplizumab was approved for use in a very narrow category of patients with a relatively sma...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Endocrinology · Tufts Medical Center Physicians Organization
Answered on

The presence of HLA-DR4, absence of HLA-DR3, and absence of anti-zinc transporter 8 antibody predicted a response to teplizumab to delay the onset of stage 3 type 1 diabetes.

Join for free or sign in to see the full answer